Whole exome sequencing (WES) test
WES is Whole Exome Sequencing (Whole Exome Sequencing), i.e. exomes (coding fragments) of all, i.e. more than 23 500 human genes.
In the human genome (all DNA) there are more than 180,000 exons, which accounts for less than 2% of the total sequence, but within the exome there are about 80-90% of the mutations responsible for the diseases.
The test is performed using technology NGS, or Next Generation Sequencing. The WES study has huge advantage over standard genetic tests, in which only single mutations within a gene are analyzed.
m
Why is our approach innovative, compared to other laboratories?
The waiting time for the result is only 4 weeks from the delivery of the material to the labotarium
The patient has the option to purchase subscription (does not burden his budget in this way one time)
As part of the subscription, the patient can select additionalany analysis (if a particular disease entity we will create such a panel of tests up to 7 days).
The analysis of sequencing data performed in our laboratory includes all known mutations, also referred to as variants or so-called SNPs. SNPs (single-nucleotide polymorphisms)associated with a particular disease entity.
The result of bioinformatics analysis determines the clinical status of the detected variants, predictive analysis, and visualization of the obtained results.
The result of the test is consulted with specialist in the relevant medical field.
Each result is updated with the latest scientific data every 6 months.
Find the genetic test (type in the name of the disease unit or gene)
-
The study involves the analysis of 248506 genetic variations in 579 genes associated with: childhood autism, atypical autism, Asperger's syndrome.
-
The study includes analysis of trisomy 21 trisomy 18 trisomy 13 aneuploidy chomosome genetic sex
-
The study includes analysis of 79332 genetic variations in 273 genes associated with: recurrent miscarriages. reproductive failure.
-
The study involves the analysis of 79332 genetic variations in 301 genes associated with: male infertility, female infertility, reproductive failure.
-
The study includes analysis of 8121 genetic variations in 47 genes associated with: pre-eclampsia, eclampsia.
-
The study includes analysis of 4740 genetic variations in 81 genes associated with: bronchial asthma.
-
The study includes analysis of 9034 genetic variations in 24 genes associated with: thrombophilia (hypercoagulability).
-
The study includes an analysis of 23469 genetic variations in 52 genes associated with: hypopigmentation, vitiligo, and Hermanski-Pudlak syndrome.
-
The study includes analysis of 14660 genetic variations in 68 genes associated with: psoriasis pilaris, plaque psoriasis, lichen herpetiformis, Von Zumbusch disease, continuous pustular inflammation of the extremities [acrodermatitis continua], pustular psoriasis of the palms and soles, papular psoriasis, psoriatic arthritis, and inverse psoriasis.
-
The study includes analysis of 30010 genetic variations in 40 genes associated with: aortic dissection, aortic aneurysm.
-
The study includes analysis of 7708 genetic variations in 15 genes associated with: hypercholesterolemia, hypertriglycerinemia, mixed hyperlipidemia, and hyperalphalipoproteinemia.
-
The study includes analysis of 73165 genetic variations in 132 genes associated with: Brugada syndrome, long QT syndrome, short QT syndrome.
-
The study includes analysis of 19850 genetic variations in 13 genes associated with: follicular carcinoma, papillary carcinoma, micronodular carcinoma, poorly differentiated thyroid cancer, undifferentiated thyroid cancer, medullary carcinoma.
-
The study includes analysis of 12163 genetic variations in 33 genes associated with: paranoid schizophrenia, hebephrenic schizophrenia, catatonic schizophrenia, undifferentiated schizophrenia, residual schizophrenia, and simple schizophrenia.
-
The study includes an analysis of 31232 genetic variations in 20 genes associated with the following: pivot-type adenocarcinoma, medullary carcinoma, microadenocarcinoma, mucinous adenocarcinoma, serrated adenocarcinoma, signet ring cell carcinoma, adenocarcinoma, spindle cell carcinoma, and squamous cell carcinoma.
-
The study includes analysis of 59532 genetic variations in 17 genes associated with: adenocarcinoma, follicular cell carcinoma, cancer of embryonal origin, solid pseudopapillary carcinoma, anaplastic carcinoma, gastrin tumor, insulin tumor, glucagon tumor, vasoactive intestinal peptide secreting tumor, somatostatin tumor.
-
The study includes analysis of 31232 genetic variations in 20 genes associated with: bronchial or lung adenocarcinoma, small cell bronchial or lung cancer, squamous cell bronchial or lung cancer, large cell bronchial or lung cancer.
-
The study includes analysis of 7471 genetic variations in 29 genes associated with: Parkinson's disease, atypical parkinsonism, secondary parkinsonism, and functional parkinsonism.
